The results of immunomonitoring of peripheral blood revealed that the present comprehensive cancer immunotherapy showed a significant increase in CD8+ T cell count and a significant decrease in Treg ratio, particularly in SD patients with locally advanced pancreatic carcinoma. This evidence concerns the gene CD8A and cancer.